Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Nucleic acids separation and purification company enters supply agreement
June 6th, 2005
QIAGEN N.V. (QGEN, QIA) announced that its wholly owned subsidiary QIAGEN GmbH has entered into a manufacturing and supply agreement with Beckman Coulter, Inc. (BEC). Beckman Coulter intends to market two of QIAGEN's automated sample preparation kits for use with their new Vidiera NsP nucleic acid sample preparation platform. The two customized kits will incorporate a modified version of QIAGEN's market and technology leading QIAamp technology for automated and reliable purification of viral nucleic acids from serum and plasma samples, as well as genomic DNA from blood samples. QIAGEN's proprietary nucleic acid sample preparation kits provide highest...
Source: Biotech Business Week (2005-06-06)
|
